We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Biotech's autumn effect

8 December 2006 By Robert Cyran

The industry has generally been a volatile investment. But the sector has turned in positive results from August to January for decades. This isn t a case of data mining. The schedule of medical conferences and regulatory calendars explain the outperformance.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)